Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Diabetes risk reduction diet and the risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial | Yuanhao Chen | Department of Urology,Beijing Chaoyang Hospital Affiliated To Capital Medical University | PLCO | Jan 3, 2023 | PLCO-1138 |
| Prostate Cancer Clinical Outcomes | K.C Balaji | UF Health Jacksonville | PLCO | Jan 3, 2023 | PLCO-1139 |
| The association between dietary approaches to stop hypertension eating pattern and the risk of lung cancer in the PLCO Cancer Screening Trial | Linglong Peng | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Dec 29, 2022 | PLCO-1137 |
| Spatial and socioeconomic disparity in the colorectal cancer screening rate | Yoshito Nishimura | University of Hawaii | PLCO | Dec 27, 2022 | PLCO-1135 |
| Optimizing combination of chemotherapy and checkpoint inhibitors of oncology treatment by offline deep reinforcement learning | Yao Yao | City University of Hong Kong | PLCO | Dec 27, 2022 | PLCO-1133 |
| The Sulfur Microbial Diet Is Associated with Increased Risk of Esophageal Cancer in the PLCO Cancer Screening Trial | Linglong Peng | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Dec 23, 2022 | PLCO-1134 |
| Computational Pathology in Ovarian Cancer | Sandra Orsulic | Regents University of California Los Angeles | PLCO | Dec 19, 2022 | PLCOI-1132 |
| Associations of Dietary Factors with Risk of Chronic Disease and Mortality | Jiaqi Huang | The Second Xiangya Hospital of Central South University | PLCO | Dec 19, 2022 | PLCO-1131 |
| Indirect comparisons of screening strategies and generalizing effects to a nationally representative population by combining trial data | Issa Dahabreh | President and Fellows of Harvard College on behalf of Harvard T.H. Chan School of Public Health | PLCO | Dec 19, 2022 | PLCO-1130 |
| Radiographic health assessment of cardiovascular disease risk, smoking damage, and lung cancer screening. | Richard Du | Detect Medical Technology Limited | NLST | Dec 12, 2022 | NLST-996 |
| Meta-data for CRDC pilot study | Eric Miller | National Cancer Institute | PLCO | Dec 9, 2022 | PLCO-1128 |
| AI-driven Automatic Chest X-Ray Cardiovascular structure quantification for Cardiovascular Risk Estimation | Richard Du | Detect Medical Technology Limited | PLCO | Dec 8, 2022 | PLCOI-1122 |
| Early Warning of Ovarian Cancer | Michael Korenberg | Queen's University | PLCO | Dec 8, 2022 | PLCO-1126 |
| Association between positive cancer screening and death from cardiovascular disease | yubei huang | Tianjin Medical University Cancer Institute and Hospital | PLCO | Dec 8, 2022 | PLCO-1125 |
| Early detection of ovarian cancer via biomarkers using Machine Learning techniques | Kritika Murali | MIT Art Design and Technology University | PLCO | Dec 8, 2022 | PLCO-1124 |
| Non-lung cancer incidence in NLST | Ellen Chang | GRAIL, LLC | NLST | Dec 8, 2022 | NLST-995 |
| Medical Image Based Prognosis for Lung Cancer Patients | Hongda Zhang | Nanjing University | NLST | Dec 8, 2022 | NLST-994 |
| Machine Learning with Low Dose CT Data | Bennett Landman | Vanderbilt University | NLST | Dec 8, 2022 | NLST-993 |
| Development of anti-lung cancer screening system based on target recognition and natural language | Yuan Dan | Wuhan University of Science and Technology | NLST | Dec 6, 2022 | NLST-991 |
| Treatment effect in a proportional hazards model with instrumental variables | lorenzo tedesco | KU LEUVEN | HIPB | Dec 5, 2022 | HIPB-10 |